Calithera Biosciences, Inc.
Ectonucleotidase inhibitors and methods of use thereof
Last updated:
Abstract:
The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treating or preventing cancer using the novel heterocyclic compounds of the invention.
Status:
Grant
Type:
Utility
Filling date:
21 Dec 2017
Issue date:
25 Feb 2020